Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen Deloose

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Surgical Technology International|October 12, 2017
AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular ProceduresEmily Benham, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|October 22, 2014
Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
Journal of Vascular Surgery|August 1, 2007
The type of embolic protection does not influence the outcome in carotid artery stentingVikram Iyer, Gianmarco de Donato, Koen Deloose, et al.
Annals of Vascular Surgery|March 4, 2015
24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D LesionsGianmarco de Donato, Marc Bosiers, Francesco Setacci, et al.
The Journal of Cardiovascular Surgery|July 15, 2024
Comparative analysis of carotid artery stenting practice and outcomes across operator specialties: insights from a prespecified subanalysis of a large real-world patient cohort (ROADSAVER Study)Arne Schwindt, Sasko Kedev, Zsolt Vajda, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|March 6, 2024
The BioMimics 3D Helical Centreline Nitinol Stent in Chronic Limb Threatening Ischaemia and Complex Lesions: Three Year Outcomes of the MIMICS-3D RegistryChristos Rammos, Thomas Zeller, Michael Piorkowski, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
BioMimics 3D Stent in Femoropopliteal Lesions: 3-Year Outcomes with Propensity Matching for Drug-Coated BalloonsMichael Piorkowski, Thomas Zeller, Christos Rammos, et al.
The Journal of Cardiovascular Surgery|April 18, 2019
One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patientsKim Taeymans, Marc Bosiers, Koen Deloose, et al.
The Journal of Cardiovascular Surgery|May 27, 2017
BeGraft Peripheral PMCF Study: 12-month resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|January 29, 2025
A Belgian physician-initiated trial investigating the LifeStream peripheral stent graft system for the treatment of complex TASC C and D iliac lesionsKoen Deloose, Jan Gielis, Lieven Maene, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Surgical Technology International|October 12, 2017
AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular ProceduresEmily Benham, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|October 22, 2014
Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
Journal of Vascular Surgery|August 1, 2007
The type of embolic protection does not influence the outcome in carotid artery stentingVikram Iyer, Gianmarco de Donato, Koen Deloose, et al.
Annals of Vascular Surgery|March 4, 2015
24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D LesionsGianmarco de Donato, Marc Bosiers, Francesco Setacci, et al.
The Journal of Cardiovascular Surgery|July 15, 2024
Comparative analysis of carotid artery stenting practice and outcomes across operator specialties: insights from a prespecified subanalysis of a large real-world patient cohort (ROADSAVER Study)Arne Schwindt, Sasko Kedev, Zsolt Vajda, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|March 6, 2024
The BioMimics 3D Helical Centreline Nitinol Stent in Chronic Limb Threatening Ischaemia and Complex Lesions: Three Year Outcomes of the MIMICS-3D RegistryChristos Rammos, Thomas Zeller, Michael Piorkowski, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
BioMimics 3D Stent in Femoropopliteal Lesions: 3-Year Outcomes with Propensity Matching for Drug-Coated BalloonsMichael Piorkowski, Thomas Zeller, Christos Rammos, et al.
The Journal of Cardiovascular Surgery|April 18, 2019
One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patientsKim Taeymans, Marc Bosiers, Koen Deloose, et al.
The Journal of Cardiovascular Surgery|May 27, 2017
BeGraft Peripheral PMCF Study: 12-month resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|January 29, 2025
A Belgian physician-initiated trial investigating the LifeStream peripheral stent graft system for the treatment of complex TASC C and D iliac lesionsKoen Deloose, Jan Gielis, Lieven Maene, et al.
Pageof 8